Covid

Results

Medtecs reports a loss for 1HFY2022 as demand and selling prices drop

The company warns that for the current 2HFY2022, it sees a continued drop in demand.

Behind the Bottle

Penfolds’ legendary chief winemaker Peter Gago shares his top tips

Penfolds chief winemaker Peter Gago recommends the best dishes to pair with his wines
Three doses of Pfizer-BioNTech vaccine may neutralise Omicorn - THE EDGE SINGAPORE

Covid-19

Three doses of Pfizer-BioNTech vaccine may neutralise Omicron

Initial laboratory studies demonstrate that three doses of the Pfizer-BioNTech Covid-19 Vaccine neutralize the Omicron variant
Markets pressured by Covid with HSI heading lower as STI hits support - THE EDGE SINGAPORE

Right Timing

Markets pressured by Covid with HSI heading lower as STI hits support

A Covid mutation in South Africa has unnerved markets, causing the STI to fall to its support, and the HSI to break support
Deferment of BeerCo IPO may be opportunity to accumulate ThaiBev stocks: Maybank Kim Eng - THE EDGE SINGAPORE

Broker's Calls

Deferment of BeerCo IPO may be opportunity to accumulate ThaiBev stocks: Maybank Kim Eng

To Maybank's Chan, the deferment of BeerCo’s IPO is more likely due to a lower-than-expected valuation for the business.
Vicplas International reports 2.2 times earnings growth for 1HFY21 - THE EDGE SINGAPORE

Results

Vicplas International reports 2.2 times earnings growth for 1HFY21

Revenue from its medical segment grew 36% on increased customer orders.
Millennium & Copthorne New Zealand faces cancellations, unable to forecast exact impact on 1H21 financial performance - THE EDGE SINGAPORE

Property

Millennium & Copthorne New Zealand faces cancellations, unable to forecast exact impact on 1H21 financial performance

The number of deferrals and cancellations vary from hotel to hotel, which will impact M&C New Zealand’s revenue for February.
PhillipCapital upgrades DBS to 'accumulate' with higher TP of $29.50 on better credit outlook - THE EDGE SINGAPORE

Broker's Calls

PhillipCapital upgrades DBS to 'accumulate' with higher TP of $29.50 on better credit outlook

PhillipCapital has also upped DBS’s FY2021 earnings estimates by 6%, as it lowers allowances of $1 billion.
Analysts remain positive on UOL Group despite $82.1mil loss in 1H20 - THE EDGE SINGAPORE

Broker's Calls

Analysts remain positive on UOL Group despite $82.1mil loss in 1H20

CGS-CIMB and DBS Group have maintained a buy rating on UOL Group despite it posting a 1H20 loss of $82.1 million.
×